Trial offers hope for new revaccination strategies with Bacille Calmette-Guerin (BCG) against Tuberculosis, the world's leading infectious disease killer
A novel personalized vaccine made using patients’ tumor tissue and immune cells stimulates potent therapeutic immune responses, extending overall survival of patients with recurrent ovarian cancer